Honiara Business Journal
SEE OTHER BRANDS

Your business and economy news reporter from the Solomon Islands

Honiara Business Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Honiara Business Journal.

Press releases published on August 5, 2025

Spyre Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Spyre Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Reported positive interim Phase 1 results for two next-generation TL1A antibodies, demonstrating both were well-tolerated, exhibited pharmacokinetic ("PK") profiles supporting quarterly or biannual dosing, and full TL1A engagement through up to 20 weeks of …

Grocery Outlet Holding Corp. Announces Second Quarter Fiscal 2025 Financial Results

Grocery Outlet Holding Corp. Announces Second Quarter Fiscal 2025 Financial Results

EMERYVILLE, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Grocery Outlet Holding Corp. (NASDAQ: GO) ("Grocery Outlet," the "Company," "we" or "our") today announced financial results for the second quarter of fiscal 2025 ended June 28, 2025. Highlights for …

Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025

Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025

SCOTTSDALE, Ariz., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug …

Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne

Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne

Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne Year-over-year Q2 revenues increased by 20% to $26.6 million Adjusted EBITDA …

Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution

Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution

TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- (TSX: CBNK) Mulvihill Canadian Bank Enhanced Yield ETF has declared a monthly cash distribution in the amount of $0.058333 per unit, payable on September 5, 2025 to unitholders of record on August 29, 2025. For …

Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution

Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution

TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- (TSX: SPFD) Mulvihill Enhanced Split Preferred Share ETF has declared a monthly cash distribution in the amount of $0.08333 per unit, payable on September 5, 2025 to unitholders of record on August 29, 2025. For …

Premium Income Corporation Announces Monthly Distribution

Premium Income Corporation Announces Monthly Distribution

TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- (TSX: PIC.A; PIC.PR.A) Premium Income Corporation has declared monthly distributions payable on August 29, 2025 to shareholders of record on August 15, 2025 in the following amounts per share: Share Class  Ticker …

BridgeBio Reports Second Quarter 2025 Financial Results and Business Updates

BridgeBio Reports Second Quarter 2025 Financial Results and Business Updates

- As of August 1, 2025, 3,751 unique patient prescriptions have been written by 1,074 unique prescribers, representing an accelerating launch driven by strong month over month growth in the crucial treatment naïve patient segment - $110.6 million in total …

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2025

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2025

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Generated Product Revenues of $79 million for the Three Months Ended June 30 Awarded Additional Development Funding of $27 million under the BARDA 19C Contract during the Three Months Ended June 30 Corporate …

United Fire Group, Inc. reports second quarter 2025 results

United Fire Group, Inc. reports second quarter 2025 results

Second quarter net income of $0.87 per diluted share and adjusted operating income of $0.90 per diluted share Second quarter 2025 highlights compared to second quarter 2024, unless otherwise noted:(1) Net income increased $25.7 million to $22.9 million. …

SLR Investment Corp. Announces Quarter Ended June 30, 2025 Financial Results

SLR Investment Corp. Announces Quarter Ended June 30, 2025 Financial Results

Net Investment Income of $0.40 Per Share for Q2 2025; Stable NAV/Strong Credit Quality; Declared Quarterly Distribution of $0.41 Per Share NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- SLR Investment Corp. (NASDAQ: SLRC) (the “Company”, “SLRC”, “we”, “us”, …

Carlyle Secured Lending, Inc. Announces Financial Results For Second Quarter Ended June 30, 2025, Declares Third Quarter 2025 Dividend of $0.40 Per Common Share

Carlyle Secured Lending, Inc. Announces Financial Results For Second Quarter Ended June 30, 2025, Declares Third Quarter 2025 Dividend of $0.40 Per Common Share

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, “we,” “us,” “our,” “CGBD” or the “Company”) (NASDAQ: CGBD) today announced its financial results for its second quarter ended June 30, …

IRBT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that iRobot Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

IRBT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that iRobot Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz …

AAPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Apple Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

AAPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Apple Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

LINE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lineage, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

LINE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lineage, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

NVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025

Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025

NEWTON, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the …

Comscore Reports Second Quarter 2025 Results

Comscore Reports Second Quarter 2025 Results

RESTON, Va., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Comscore, Inc. (Nasdaq: SCOR), a trusted partner for planning, transacting and evaluating media across platforms, today reported financial results for the quarter ended June 30, 2025. "Our execution through …

Day One Reports Second Quarter 2025 Financial Results and Corporate Progress

Day One Reports Second Quarter 2025 Financial Results and Corporate Progress

OJEMDA™ (tovorafenib) net product revenue of $33.6 million in Q2 2025, a 10% quarter-over-quarter increase OJEMDA full-year 2025 net product revenue expected to be $140 to $150 million Ended the second quarter with $453.1 million in cash, cash equivalents …

Pacira BioSciences Reports Second Quarter 2025 Financial Results

Pacira BioSciences Reports Second Quarter 2025 Financial Results

-- Solid execution across corporate, clinical and commercial initiatives -- -- Several key milestones advance 5x30 path to growth -- -- Conference call today at 4:30 p.m. ET -- BRISBANE, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. ( …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions